Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Harpole

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancerMary-Beth Moore Joshi, Yoshinori Shirota, Kathleen D Danenberg, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 2019
The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancerVignesh Raman, Oliver K Jawitz, Chi-Fu J Yang, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2020
Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgeryNorma E Farrow, Selena J An, Paul J Speicher, et al.
Annals of Surgery|August 12, 2017
A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung CancerChi-Fu Jeffrey Yang, Arvind Kumar, Jacob A Klapper, et al.
Annals of Surgery|August 8, 2012
Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysisDuyKhanh P Ceppa, Andrzej S Kosinski, Mark F Berry, et al.
Annals of Surgery|May 6, 2017
Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung CancerChi-Fu Jeffrey Yang, Derek Y Chan, Shivani A Shah, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 29, 2010
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS databaseSubroto Paul, Nasser K Altorki, Shubin Sheng, et al.
The Journal of Surgical Research|March 21, 2015
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results databaseRobert Ryan Meyerhoff, Chi-Fu Jeffrey Yang, Paul J Speicher, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 14, 2021
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancerBetty C Tong, Lin Gu, Xiaofei Wang, et al.
Annals of Surgical Oncology|February 18, 2006
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinomaJeffrey G Gaca, Rebecca P Petersen, Bercedis L Peterson, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancerMary-Beth Moore Joshi, Yoshinori Shirota, Kathleen D Danenberg, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 2019
The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancerVignesh Raman, Oliver K Jawitz, Chi-Fu J Yang, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2020
Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgeryNorma E Farrow, Selena J An, Paul J Speicher, et al.
Annals of Surgery|August 12, 2017
A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung CancerChi-Fu Jeffrey Yang, Arvind Kumar, Jacob A Klapper, et al.
Annals of Surgery|August 8, 2012
Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysisDuyKhanh P Ceppa, Andrzej S Kosinski, Mark F Berry, et al.
Annals of Surgery|May 6, 2017
Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung CancerChi-Fu Jeffrey Yang, Derek Y Chan, Shivani A Shah, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 29, 2010
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS databaseSubroto Paul, Nasser K Altorki, Shubin Sheng, et al.
The Journal of Surgical Research|March 21, 2015
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results databaseRobert Ryan Meyerhoff, Chi-Fu Jeffrey Yang, Paul J Speicher, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 14, 2021
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancerBetty C Tong, Lin Gu, Xiaofei Wang, et al.
Annals of Surgical Oncology|February 18, 2006
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinomaJeffrey G Gaca, Rebecca P Petersen, Bercedis L Peterson, et al.
Pageof 13